Page last updated: 2024-10-31

midazolam and Arteriosclerosis

midazolam has been researched along with Arteriosclerosis in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marty, J1
Fisher, GC1
Hutton, P1

Other Studies

2 other studies available for midazolam and Arteriosclerosis

ArticleYear
[Use of midazolam in the patient with atherosclerosis].
    Cahiers d'anesthesiologie, 1995, Volume: 43, Issue:2

    Topics: Anesthetics; Arteriosclerosis; Hemodynamics; Humans; Hypotension; Midazolam

1995
Cardiovascular responses to flumazenil-induced arousal after arterial surgery.
    Anaesthesia, 1989, Volume: 44, Issue:2

    Topics: Anesthesia Recovery Period; Anesthesia, Intravenous; Arousal; Arteries; Arteriosclerosis; Blood Pres

1989